FIM
ABBV icon

Fruth Investment Management’s AbbVie ABBV Stock Holding History

Fruth Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,551
Closed -$1.56M – 217
2024
Q1 		$1.56M Sell
8,551
-250
-3% -$43.1K 0.4% 76
2023
Q4 		$1.36M Sell
8,801
-475
-5% -$69.3K 0.38% 78
2023
Q3 		$1.38M Sell
9,276
-500
-5% -$73.4K 0.41% 77
2023
Q2 		$1.32M Sell
9,776
-386
-4% -$56.6K 0.37% 81
2023
Q1 		$1.62M Sell
10,162
-742
-7% -$113K 0.47% 68
2022
Q4 		$1.76M Sell
10,904
-8,698
-44% -$1.33M 0.52% 64
2022
Q3 		$2.63M Sell
19,602
-5,425
-22% -$778K 0.87% 29
2022
Q2 		$4.1M Sell
25,027
-3,515
-12% -$537K 1.12% 22
2022
Q1 		$4.63M Sell
28,542
-50
-0.2% -$7.26K 1.28% 18
2021
Q4 		$3.87M Sell
28,592
-355
-1% -$41.9K 1.06% 27
2021
Q3 		$3.12M Sell
28,947
-30
-0.1% -$3.43K 0.96% 31
2021
Q2 		$3.26M Sell
28,977
-735
-2% -$82.8K 0.97% 31
2021
Q1 		$3.21M Hold
29,712
– – 1.01% 30
2020
Q4 		$3.18M Sell
29,712
-575
-2% -$55.3K 1.11% 29
2020
Q3 		$2.65M Sell
30,287
-750
-2% -$70.6K 1.06% 31
2020
Q2 		$3.05M Buy
31,037
+486
+2% +$42.8K 1.28% 23
2020
Q1 		$2.33M Hold
30,551
– – 1.19% 27
2019
Q4 		$2.7M Sell
30,551
-364
-1% -$30.2K 1.02% 31
2019
Q3 		$2.34M Sell
30,915
-150
-0.5% -$10.3K 0.94% 33
2019
Q2 		$2.26M Sell
31,065
-325
-1% -$25.5K 0.91% 34
2019
Q1 		$2.53M Sell
31,390
-3,090
-9% -$253K 1.06% 30
2018
Q4 		$3.18M Sell
34,480
-700
-2% -$61.6K 1.5% 16
2018
Q3 		$3.33M Sell
35,180
-100
-0.3% -$9.48K 1.34% 18
2018
Q2 		$3.27M Hold
35,280
– – 1.41% 18
2018
Q1 		$3.34M Sell
35,280
-1,085
-3% -$119K 1.48% 16
2017
Q4 		$3.52M Sell
36,365
-380
-1% -$35.8K 1.49% 15
2017
Q3 		$3.27M Sell
36,745
-300
-0.8% -$22.8K 1.5% 14
2017
Q2 		$2.69M Sell
37,045
-400
-1% -$26.9K 1.26% 20
2017
Q1 		$2.44M Sell
37,445
-1,174
-3% -$73.8K 1.14% 21
2016
Q4 		$2.42M Buy
38,619
+284
+0.7% +$17.3K 1.1% 21
2016
Q3 		$2.42M Sell
38,335
-400
-1% -$25.9K 1.2% 21
2016
Q2 		$2.4M Sell
38,735
-150
-0.4% -$9.14K 1.14% 23
2016
Q1 		$2.22M Buy
38,885
+41
+0.1% +$2.29K 1.11% 21
2015
Q4 		$2.3M Sell
38,844
-100
-0.3% -$5.76K 1.17% 22
2015
Q3 		$2.12M Sell
38,944
-669
-2% -$43.5K 1.1% 22
2015
Q2 		$2.66M Sell
39,613
-350
-0.9% -$22.8K 1.25% 17
2015
Q1 		$2.34M Buy
39,963
+82
+0.2% +$4.95K 1.01% 25
2014
Q4 		$2.61M Sell
39,881
-295
-0.7% -$18.6K 1.1% 21
2014
Q3 		$2.32M Buy
40,176
+445
+1% +$24.7K 1.02% 23
2014
Q2 		$2.28M Sell
39,731
-415
-1% -$21.8K 1.04% 25
2014
Q1 		$1.98M Sell
40,146
-250
-0.6% -$12.6K 0.94% 30
2013
Q4 		$2.13M Buy
40,396
+29
+0.1% +$1.43K 1.02% 24
2013
Q3 		$1.8M Sell
40,367
-1,250
-3% -$55.4K 0.95% 31
2013
Q2 		$1.72M Buy
+41,617
New +$1.82M 0.97% 30

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Fruth Investment Management's ABBV Position: Q2 2024 in Review

Fruth Investment Management sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 8,551 shares — an estimated $1.56M sold.

Fruth Investment Management first reported a position in ABBV in Q2 2013 and held it in 44 quarters. The position peaked at $4.63M in Q1 2022. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • Fruth Investment Management reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
  • Fruth Investment Management sold 8,551 AbbVie shares in Q2 2024, an estimated $1.56M.
  • Fruth Investment Management first reported a position in AbbVie in Q2 2013 and held it in 44 quarters.
  • Fruth Investment Management's AbbVie position peaked at $4.63M in Q1 2022.
  • 3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Fruth Investment Management's 13F filing for Q2 2024, filed 18 Jul 2024.